{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Long non-coding RNA",
      "UCA1",
      "biomarker",
      "cancer",
      "regulatory mechanism",
      "therapy"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32560605",
  "DateCompleted": {
    "Year": "2021",
    "Month": "12",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "27"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2174/1566524020666200619124543"
    ],
    "Journal": {
      "ISSN": "1875-5666",
      "JournalIssue": {
        "Volume": "21",
        "Issue": "2",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Current molecular medicine",
      "ISOAbbreviation": "Curr Mol Med"
    },
    "ArticleTitle": "The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study.",
    "Pagination": {
      "StartPage": "96",
      "EndPage": "110",
      "MedlinePgn": "96-110"
    },
    "Abstract": {
      "AbstractText": [
        "In various cancers, high-grade tumor and poor survival rate in patients with upregulated lncRNAs UCA1 have been confirmed. Urothelial carcinoma associated 1 (UCA1) is an oncogenic non-coding RNA with a length of more than 200 nucleotides. The UCA1 regulate critical biological processes that are involved in cancer progression, including cancer cell growth, invasion, migration, metastasis, and angiogenesis. So It should not surprise that UCA1 overexpresses in variety of cancers type, including pancreatic cancer, ovarian cancer, gastric cancer, colorectal cancer, breast cancer, prostate cancer, endometrial cancer, cervical cancer, bladder cancer, adrenal cancer, hypopharyngeal cancer, oral cancer, gallbladder cancer, nasopharyngeal cancer, laryngeal cancer, osteosarcoma, esophageal squamous cell carcinoma, renal cell carcinoma, cholangiocarcinoma, leukemia, glioma, thyroid cancer, medulloblastoma, hepatocellular carcinoma and multiple myeloma. In this article, we review the biological function and regulatory mechanism of UCA1 in several cancers and also, we will discuss the potential of its as cancer biomarker and cancer treatment."
      ],
      "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran."
          }
        ],
        "LastName": "Hosseini",
        "ForeName": "Nashmin Fayazi",
        "Initials": "NF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran."
          }
        ],
        "LastName": "Manoochehri",
        "ForeName": "Hamed",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran."
          }
        ],
        "LastName": "Khoei",
        "ForeName": "Saeideh Gholamzadeh",
        "Initials": "SG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran."
          }
        ],
        "LastName": "Sheykhhasan",
        "ForeName": "Mohsen",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Curr Mol Med",
    "NlmUniqueID": "101093076",
    "ISSNLinking": "1566-5240"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Long Noncoding"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "UCA1 RNA, human"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression Regulation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [
        "drug therapy",
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "genetics"
      ],
      "DescriptorName": "RNA, Long Noncoding"
    }
  ]
}